Guidelines for emergency management of acute heart failure: Consensus of the Acute Heart Failure Working Group of the Spanish Society of Emergency Medicine (ICA-SEMES) in 2011;Manejo de la insuficiencia cardiaca aguda en los servicios de urgencias, emergencias y unidades adscritas. Documento de consenso del Grupo de Insuficiencia Cardiaca Aguda de la Sociedad Española de Medicina de Urgencias y Emergencias (ICA-SEMES)

Emergencias

Volumn 23, Issue 2, 2011, Pages 119-139

  Llorens, Pere ^a   Miró, Òscar ^b   Martín Sánchez, Francisco Javier ^c   Herrero Puente, Pablo ^d   Jacob Rodríguez, Javier ^e   Gil, Víctor ^b   Perello, Rafael ^b   Aguirre, Alfons ^f   Valero, Amparo ^g  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Acute heart failure; Emergency health services; Treatment

Indexed keywords

EID: 79955016350     PISSN: 11376821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart. 2000;83:596-602.
2. Rodríguez-Artalejo J, Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol. 2004;57:163-70.
3. Moreno Millán E, García Torrecillas JM, Lea Pereira MC. Diferencias de gestión entre los ingresos urgentes y los programados en función de los grupos relacionados de diagnóstico y la edad de los pacientes. Emergencias. 2007;19:122-8.
4. Llorens P, Martín FJ, González-Armengol JJ, Herrero P, Jacob J, Álvarez AB, et al. Perfil clínico de los pacientes con insuficiencia cardiaca en los servicios de urgencias: Datos preliminares del Estudio EAHFE (Epidemiology Acute Heart Failure Emergency). Emergencias. 2008;20:154-63.
5. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J. 2005;26:384-416.
6. Mebazaa A, Gheorghiade M, Piña I, Harjola VP, Hollenberg S, Follath F, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med. 2008;36(supl):S129-S139.
7. Fonarow GC. The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitali-zed with acute decompensated heart failure. Rev Cardiovas Med. 2003;4(supl 7):S21-S30.
8. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, et al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43-51.
9. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndormes. Eur Hear J. 2010;31:784-93.
10. Dickstein K, Cohen-Solal A, Filippatos G, McMurray J, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008;29:2388-442.
11. Collins S, Storrow A, Kirk J, Pang P, Diecks D, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med. 2008;51:45-57.
12. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321:215-8.
13. Caramelo C, Justo S, Gil P. Anemia en la insuficiencia cardiaca: fisiopatología, patogenia, tratamiento e incógnitas. Rev Esp Cardiol. 2007;60:848-60.
14. Walsh MN, Tavel ME. Evaluation and management of a patient with congestive heart failure. Chest. 2003;124:728-31.
15. Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail. 2006;12:e16-e25.
16. Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, et al. Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med. 2004;116:363-8.
17. Collins, SP, Lindsell, CJ, Storrow, AB, Abraham, WT. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med. 2006;47:13-8.
18. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117-26.
19. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin Elevation in Heart Failure: Prevalence, Mechanisms, and Clinical Implications. J Am Coll Cardiol. 2010;56:1071-8.
20. Ray P, Delerme S, Jourdan P, Chevenier-Gobeaux C. Review diagnosis of acute dyspnea: value of B natriuretic peptides in the emergency department. QJM. 2008;1:831-43.
21. Januzzi JL, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. 2008;101(supl):29A-38A.
22. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF, et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-39.
23. Baggish AL, van Kimmenade RRJ, Januzzi JL. Amino-terminal pro-BNP type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with heart failure. Am J Cardiol. 2008;101(supl):49A-55A.
24. Jiménez-Navarro M, Delgado-Jiménez J, Rivera-Otero M, Roig-Minguell E, Segovia-Cubero J, Almenar-Bonet L, et al. Utilidad de los péptidos natriuréticos en la insuficiencia cardiaca. Med Clin (Barc). 2008;130:591-6.
25. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-68.
26. Burke MA, Cotts WG. Interpretation of B-type peptide in cardiac disease and other comorbid conditions. Heart Fail Rev. 2007;12:23-36.
27. Schneider HG, Lam L, Lokuge A, Krum H, Naughton MT, De Villiers Smit P, et al. B-Type Natriuretic Peptide Testing, Clinical Outcomes, and Health Services Use in Emergency Department Patients With Dyspnea: A Randomized Trial. Ann Intern Med. 2009;150:365-71.
28. Jacob J, Llorens P, Martín-Sánchez FJ, Herrero P, Álvarez A, Pérez-Durá MJ, et al. Valor del NT-proBNP en la asistencia al paciente con insuficiencia cardiaca aguda en los servicios de urgencias. Estudio PICASU. Emergencias. 2011;23:en prensa.
29. Jensen E, Sloth K, Larsen M. Transthoracic echocardiography for cardiopulmonary monitoring in intensive care. Eur J Anaesthesiol. 2004;21:700-7.
30. Nogue-Bou R. La ecografía en medicina de urgencias, una herramienta al alcance de los urgenciólogos. Emergencias. 2008;20:75-7.
31. Masip AE, Alonso-Gómez AM, Martín-Durán R, Moreno-Yagüela M, Oliver-Ruiz JM, Rodríguez-Padial L. Guías de práctica clínica de la Sociedad Española de Cardiología en ecocardiografía. Rev Esp Cardiol. 2000;53:663-83.
32. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-73.
33. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87:643-8.
34. Nohria A, Mileniczuk LM, Stevenson LW. Evaluation and monitoring of patient with acute heart failure syndromes. Am J Cardiol. 2005;96(supl):32G-40G.
35. De Luca L, Fonarow GC, Adams KF, Mebazaa A, Tavazzi L, Sweldberg K, et al. Acute heart failure syndromes: clinical scenarios and pathophysiologic targets therapy. Heart Fail Rev. 2007;12:97-104.
36. Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock. Crit Care Med. 2008;36(supl):S66-S74.
37. Ware LB, Matthay MA. Clinical practice. Acute pulmonary edema. N Engl J Med. 2005;353:2788-96.
38. Skhiri M, Hunt SA, Denault AY, François Haddad F. Tratamiento basado en la evidencia de la insuficiencia cardiaca derecha: una revision sistemática de un campo empírico. Rev Esp Cardiol. 2010;63:451-71.
39. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-26.
40. Squara P, Denjean D, Estagnasie P, Brusset A, Dib JC, Dubois C. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007;33:1191-4.
41. Keren H, Burkhoff D, Squara P. Evaluation of a noinvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007;293:583-9.
42. Raval NY, Squara P, Cleman M, Yalamanchili K, Winklmaier M, Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008;22:113-9.
43. Llorens P. Implicación de las nuevas guías del a Sociedad Europea de Cardiología en el tratamiento de la insuficiencia cardiaca agua: ¿debemos de cambiar nuestros esquemas en urgencias? Emergencias. 2009;21:143-7.
44. Baz JA, Barrabés J, Pinar E, Albarrán A, Mauri J. Técnicas actuales en la angioplastia primaria. Manejo actual del shock cardiogénico. Rev Esp Cardiol. 2009;9:17-26.
45. Van de Werf F, Bax J, Betrium A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol. 2009;62:e1-e47.
46. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guía de Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2007;60:e1-e80.
47. Ayuso-Baptista F, Jiménez-Moral G, Fonseca del Pozo JF. Manejo de la insuficiencia respiratoria aguda con ventilación mecánica no invasive en urgencias y emergencias. Emergencias. 2009;21:189-202.
48. Roca O, Riera J, Torres F, Masclans JR. High-flow therapy in acute respiratory failure. Respir Care. 2010;55:408-13.
49. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005;50:604-9.
50. Carratalá JM, Masip J. Ventilación no invasiva en la insuficiencia cardiaca aguda: uso de CPAP en los servicios de urgencias. Emergencias. 2010;22:49-55.
51. Lista-Arias E, Jacob-Rodríguez J, Palom-Rico X, Llopis-Roca F, Alonso-Fernández G. CPAP de Boussignac en urgencias. Emergencias. 2010;22:315-6.
52. Masip J. Non-Invasive ventilation. Heart Fail Rev. 2007;12:119-24.
53. Moritz F, Brousse B, Gellée B, Chajara A, L'Her E, Hellot MF, et al. Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial. Ann Emerg Med. 2007;50:666-75.
54. Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J, for the 3CPO Trialist. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359:142-51.
55. Weng CL, Zhao YT, Liu QH, Fu CJK, Sun F, Ma YJ, et al. Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med. 2010;152:590-600.
56. Carratalá JM, Llorens P, Brouzet B, Carbajosa J, Albert-Jiménez AR, Martínez-Beloqui E, et al. Ventilación no invasiva en insuficiencia cardiaca aguda: perfil clínico y evolución de pacientes atendidos en un servicio de urgencias hospitalario. Emergencias. 2010;22:187-92.
57. Chatila W, Nugent T, Vance G, Gaughan J, Criner GJ. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest. 2004;126:1108-15.
58. Chanques G, Constantin JM, Sauter M, Jung B, Sebbane M, Verzilli D, et al. Discomfort associated with under-humidified high-flow oxygen therapy in critically. Intensive Care Med. 2009;35:996-1003.
59. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008;25:205-9.
60. Goebel JA, Van Bakel AB. Rational use of diuretics in acute decompensated heart failure. Current Heart Failure reports. 2008;5:153-62.
61. Faris R, Flather M, Purcell H, Henein N, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol. 2002;82:149-58.
62. Felker GM. Diuretic Management in Heart Failure. Congestive Heart Fail. 2010;16(supl):S68-S72.
63. Peacok WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, et al. Impact of intravenous loop diuretic on outcomes of patients hospitalized with acute decompensated heart failure: Insight from the ADHERE Registry. Cardiology. 2009;113:12-9.
64. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, et al. Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognosis significance. Eur J Heart Fail. 2008;10:188-95.
65. Pivac N, Rumboldt Z, Sardelic S, Bagatin J, Polic S, Ljutic D, et al. Diurectic effects of furosemida infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res. 1998;18:121-8.
66. Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P. Diurectic efficacy of high dose furosemida in severe heart failure: bolus injection versus continuos infusion. J Am Coll Cardiol. 1996;28:376-82.
67. Salvador DRK, Punzalan FE, Ramos GC. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003178. DOI: 10.1002/14651858.CD003178.pub3.
68. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351:389-93.
69. Ho JE, Teerlink JR. Role of tolvaptan in acute decompensated heart failure. Expert Rev Cardiovasc Ther. 2008;6:601-8.
70. Gheorghiade M, Konstan MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Short-term clinical effects of tolvaptán an oral vasopressin antagonist, in patients hospitalized for heart failure. JAMA. 2007;297:1332-43.
71. Gheorghiade M, Gattis WA, O Connor CM, Adams KF, Elkayan U, Barbagelata A, et al. Effects of oral tolvaptán, a vasopressin antagonist, in patients hospitalized for worsening heart failure. A randomized controlled trial. JAMA. 2004;291:1963-71.
72. Konstan MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319-31.
73. Farmakis D, Filipatos G, Kremastinos DT, Gheorghiade M. Hyponatremia in heart failure. Heart Fail Rev. 2009;14:59-63.
74. Goldsmith SR. Current treatments and novel pharmacologic treatments for hiponatremia in congestive heart failure. Am J Cardiol. 2005;95(supl):14B-23B.
75. Hollenberg S. Vasodilatador in acute heart failure. Heart Fail Rev. 2007;12:143-7.
76. Elkayam U, Janmohamed M, Habib M, Hatamizadeh P. Vasodilatadors in the managament of acute heart failure. Crit Care Med. 2008;36(supl):S95-S115.
77. Howlett JG. Current treatment options for early management in acute decompensated heart failure. Can J Cardiol. 2008;24(supl):9B-14B.
78. Metra M, Teerlink JR, Voors AA, Felker GM, Milo-Cotter O, Weatherley B, et al. Vasodilatadors in treatment of acute heart failure: what we know, what we don t. Heart Fail Rev. 2009;14:299-307.
79. Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007;50:144-52.
80. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57-64.
81. Mosesso VN Jr, Dunford J, Blackwell T, Griswell JK. Prehospital therapy for acute congestive heart failure: state of the art. Prehosp Emerg Care. 2003;7:13-23.
82. Overgaard CB, Dzavik V. Inotropes and vasopressors. Review of physiology and clinical use in cardiovascular disease. Circulation. 2008;118:1047-56.
83. Petersen JW, Felker M. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36(supl):S106-S111.
84. Parissis JT, Rafouli-Stergiou P, Paraskevaidis I, Mebazaa A. Levosimendan: from basic science to clinical practice. Heart Fail Rev. 2009;14:265-75.
85. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe cardiac failure. Circulation. 2000;102:222-7.
86. Ikonomidis I, Parissis JT, Paraskevaidis I, Kourea K, Bistola V, Lekakis J, et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure. Eur J Heart Fail. 2007;9:1172-7.
87. Duygu H, Ozerkan F, Zoghi M, Nalbantgil S, Yildiz A, Akilli A, et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure. Int J Clin Pract. 2008;62:228-33.
88. Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail. 2007;13:417-21.
89. Parissis JT, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A. Inotropes in cardiac patients: update 2011. Curr Opin Crit Care. 2010;16:432-41.
90. Delaney A, Bradford C, McCaffrey J, Bagshaw SM, Lee R. Levosimendan for the treatment of acute severe heart failure: a metaanalysis of randomized controlled trials. Int J Cardiol. 2010;138:281-9.
91. Llorens-Soriano P, Carbajosa-Dalmau J, Fernández-Cañadas J, Murcia-Zaragoza J, Climent-Payá V, Laghzaoui F, et al. Experiencia clínica con levosimendan en un servicio de urgencias de un hospital de tercer nivel. Rev Esp Cardiol. 2007;60:878-82.
92. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57-64.
93. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510-24.
94. Kellum JA, Decker JM. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med. 2001;29:1526-31.
95. Holmes CL, Walley KR. Bad Medicine. Low-Dose Dopamine in the ICU. Chest. 2003;123:1266-75.
96. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-89.
97. Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, et al. B-CONVINCED: Beta-blocker continuation vs. interruption in patients with congestive heart failure hospitalized for a decompensation episode. Eur Heart J. 2009;30:2186-92.
98. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg B, et al, on behalf of the OPTIMIZE-HF Investigators and Coordinators. Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF Program. J Am Coll Cardiol. 2008;52:190-9.
99. Metra M, Torp-Pedersen C, Cleland JGF, Di Lenarda A, Komajda M, Remme WJ, et al. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail. 2007;9:901-9.
100. Martín Martínez A, Merino Llorens JL, Del Arco Galán C, Martínez Alday J, Laguna del Estal P, Arribas Ynsaurriaga F, et al. Guías para el manejo de la fibrilación auricular en los servicios de urgencies hospitalarios. Emergencias. 2002;14:243-61.
101. Camm J, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S. Guidelines for the management of atrial Fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;doi:10.1093/eurheartj/ehq278.
102. Le Jemtel TH, Margherita Padeletti M, Sanja Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49:171-80.
103. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalized patients with acute exacerbations of COPD. Thorax. 2008;63:301-5.
104. Rutten FH, Zuithoff NPA, Hak E, Grobbee DE, Hoes AW. Blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2010;170:880-7.
105. Ortiz P, Mingo A, Lozano M, Ángel-Vesga M, Ramon-Grifols J, Cas-trillo A, et al. Guía sobre la transfusión de componentes sanguíneos. Med Clin (Barc). 2005;125:389-96.
106. Peacock WF 4th, Young J, Collins S, Diercks D, Emerman C. Heart failure observation units: optimizing care. Ann Emerg Med 2006;47:22-33.
107. Collins SP, Lindsell CJ, Naftilan AJ, Peacock WF, Diercks D, Hiestand B, et al. Low-Risk Acute Heart Failure Patients: External Validation of the Society of Chest Pain Center's Recommendations. Crit Pathw Cardiol. 2009;8:99-103.
108. Parissis JT, Nikolaou M, Mebazaa A, Ikonomidis I, Delgado J, Vilas-Boas F, et al. Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management. Eur J Heart Fail. 2010;121:1193-202.
109. Formiga F, Chivite D, Manito N, Casas S, Riera A, Pujol R. Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology. 2007;108:73-8.
110. Miró O, Llorens P, Martín-Sánchez FJ, Herrero P, Pavón J, Pérez-Dura MJ, et al. Factores pronósticos a corto plazo en los ancianos atendidos en urgencias por insuficiencia cardiaca aguda. Rev Esp Cardiol. 2009;62:757-64.
111. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80.
112. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure:derivation and validation of a clinical model. JAMA. 2003;290:2581-7.
113. Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, et al. National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure: Research challenges and opportunities. J Am Coll Cardiol. 2010;56:343-51.
114. McCausland JB, Machi MS, Yealy DM. Emergency physicians' risk attitudes in acute decompensated heart failure patients. Acad Emerg Med. 2010;17:108-10.
115. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al. and on behalf of the American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Acute heart Failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims. A scientific statement from the American Heart Association. Circulation. 2010;122:1975-96.
116. Peacock WF. Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department. Rev Cardiovasc Med. 2002;3(supl):S41-S48.
117. Sánchez M, Salgado E, Miró O. Mecanismos organizativos de adaptación y supervivencia de los servicios de urgencia. Emergencias. 2008;20:48-53.
118. Fermann GJ, Collins SP. Observation units in the management of acute heart failure syndromes. Curr Heart Fail Rep. 2010;7:125-33.
119. Storrow AB, Collins SP, Lyons MS, Wagoner LE, Gibler WB, Lindsell CJ. Emergency department observation of heart failure: Preliminary analysis of safety and cost. Congest Heart Fail. 2005;11:68-72.
120. Peacock WF, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am. 2001;19:209-32.
121. Peacock WF, Fonarow GC, Ander DS, Maisel A, Hollander JE, Januzzi JL, et al. Society of chest pain centers recommendations for the evaluation and management of the observation stay acute heart failure patient: A report from the society of chest pain centers acute heart failure committee. Crit Pathw Cardiol. 2008;7:83-6.
122. Miró O, Llorens P, Martín-Sánchez FJ, Herrero P, Jacob J, Pérez-Durá MJ, et al. Predicting the risk of re-attendance for patients diagnosed with acute heart failure directly discharged from the Emergency Department. Eur J Emerg Med. 2010;17:197-202.
123. González-Armengol JG, Fernández-Alonso CM, Martín-Sánchez FJ, González-Del Castillo J, López-Farré A, Elvira C. Actividad de una unidad de corta estancia en urgencias de un hospital terciario: cuatro años de experiencia. Emergencias. 2009;21:87-94.
124. Sempere-Montes G, Morales-Suárez-Varela M, Garijo-Gómez E, Illa-Gómez MD, Palau-Muñoz P. Impacto de una unidad de corta estancia en un hospital de tercer nivel. Rev Clin Esp. 2010;210:279-83.
125. Palacios G, Emparan García de Salazar C. Impacto económico de la unidad de hospitalización de urgencias. Emergencias. 2010;22:254-8.
126. Arnold JMO, Howlett JG, Dorian P, Ducharme A, Ezekowitz JA, Gardner MJ, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure - 2008 update: Best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008;24:21-40.
127. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, et al, European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423-33.
128. Fonarow GC, Peterson E. Heart Failure Performance Measures and Outcomes. Real or Illusory Gains. JAMA. 2009;302:792-4.
129. Ballard DJ, Ogola G, Fleming NS, Stauffer BD, Leonard BM, Khetan R. Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. Int J Qual Health Care 2010;doi:10.1093/intqhc/mzq051.
130. VanSuch M, Naessens JM, Stroebel RJ, Huddleston JM, Williams AR. Effect of discharge instructions on readmission of hospitalized patients with heart failure: Do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care? Qual Saf Health Care. 2006;15:414-7.
131. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005;111:179-85.
132. Horwich TB, Hernandez AF, Liang L, Albert NM, Labresh KA, Yancy CW, et al. Get With Guidelines Steering Committee and Hospitals. Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. Am Heart J. 2009;158:451-8.